Literature DB >> 192678

Solid-phase radioimmunoassay of human immunoglobulin M and immunoglobulin G antibodies against herpes simplex virus type 1 capsid, envelope, and excreted antigens.

K O Kalimo, R J Marttila, K Granfors, M K Viljanen.   

Abstract

A solid-phase radioimmunoassay developed in our laboratory for detection of human viral immunoglobulin M (IgM) and IgG antibodies was applied to demonstrate human class-specific antibody response against capsid, envelope, and excreted antigens of herpes simplex virus type 1. In primary infections, a clear IgM and IgG antibody response was found predominantly against the envelope components, whereas the IgM and IgG antibodies to the capsid antigen appeared more slowly. Increasing IgG antibody titers to the excreted antigen were also found in primary infections, though appearing more slowly than antibodies to the other subunit antigens. The antibody response against capsid and envelope antigens was not type specific, whereas in primary infections IgG class antibodies against the excreted antigen showed distinct type specificity. In recurrent infections, no significant level of IgM class antibodies was demonstrated, but in the patients with a severe secondary herpes simplex virus infection a definite IgM class antibody response was found against the envelope antigen. In addition, during severe secondary infections the antibody response against the excreted antigen was enhanced. The host IgG antibody response in recurrent infections was directed against the envelope and excreted antigens, whereas the level of the capsid antibodies was relatively stable.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192678      PMCID: PMC421456          DOI: 10.1128/iai.15.3.883-889.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  Synthesis of proteins in cells infected with herpesvirus. X. Proteins excreted by cells infected with herpes simplex virus, types 1 and 2.

Authors:  A S Kaplan; J S Erickson; T Ben-Porat
Journal:  Virology       Date:  1975-03       Impact factor: 3.616

2.  Solid-phase radioimmunoassay of rubella virus immunoglobulin G and immunoglobulin M antibodies.

Authors:  K O Kalimo; O H Meurman; P E Halonen; B R Ziola; M K Viljanen; K Granfors; P Toivanen
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

3.  Surface antigen produced by herpes simplex virus (HSV).

Authors:  M Ito; A L Barron
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

4.  Complement-fixing antigens of herpes simplex virus types 1 and 2: reactivity of capsid, envelope, and soluble antigens.

Authors:  M L Martin; E L Palmer; R E Kissling
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

5.  Synthesis of proteins in cells infected with herpesvirus. IX. Sulfated proteins.

Authors:  J S Erickson; A S Kaplan
Journal:  Virology       Date:  1973-09       Impact factor: 3.616

6.  Radioimmunoassay of class-specific antibodies (RIACA): chicken antibodies to bovine serum albumin.

Authors:  M K Viljanen; K Granfors; P Toivanen
Journal:  Immunochemistry       Date:  1975-08

7.  Altered immunologic specificity of cells infected with Herpes simplex virus: recognition of human antiserum.

Authors:  J Schwartz; T S Elizan
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-02

8.  Antibodies to surface antigens of herpesvirus type 1- and type 2-infected cells among women with cervical cancer and control women.

Authors:  J W Smith; S P Lowry; J L Melnick; W E Rawls
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

9.  A solid-phase radioimmunoassay for IgG and IgM antibodies against measles virus.

Authors:  P Arstila; T Vuorimaa; K Kalimo; P Halonen; M Viljanen; K Granfors; P Toivanen
Journal:  J Gen Virol       Date:  1977-01       Impact factor: 3.891

10.  Reactivity of envelope, capsid, and soluble antigens of Herpesvirus hominis types 1 and 2 in the indirect hemagglutination test.

Authors:  A F Back; N J Schmidt
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

  10 in total
  20 in total

1.  Sensitive solid-phase radioimmunoassay for detection of human immunoglobulin G antibodies to varicella-zoster virus.

Authors:  M G Friedman; S Leventon-Kriss; I Sarov
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

2.  PPD-induced viral antibody production in human blood lymphocytes.

Authors:  G Biberfeld; M Forsgren; L V Von Stedingk; P Arneborn
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

3.  Seroprevalence to some TORCH agents in a Sicilian female population of fertile age.

Authors:  F Condorelli; G Scalia; A Stivala; M C Costanzo; A D Adragna; C Franceschino; M G Santagati; P M Furneri; A Marino; A Castro
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

4.  Anomalous antibody responses in viral infection: specific stimulation or polyclonal activation?

Authors:  N E Cremer; V L Devlin; J L Riggs; S J Hagens
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

5.  Evaluation of a radioimmunoassay for IgM-class antibodies against cytomegalovirus.

Authors:  H O Kangro
Journal:  Br J Exp Pathol       Date:  1980-10

6.  Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus.

Authors:  D B Burlington; M L Clements; G Meiklejohn; M Phelan; B R Murphy
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

7.  Measurement of immunoglobulin M (IgM), IgG, and IgA antibodies against Yersinia enterocolitica by enzyme-linked immunosorbent assay: persistence of serum antibodies during disease.

Authors:  K Granfors
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

8.  Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections.

Authors:  D W Ho; P R Field; W L Irving; D R Packham; A L Cunningham
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

9.  Cell-mediated immunity against herpes simplex virus envelope, capsid, excreted, and crude antigens.

Authors:  K O Kalimo; I A Joronen; V K Havu
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  Determination of specific IGA antibodies to varicella zoster virus by immunoperoxidase assay.

Authors:  H Haikin; I Sarov
Journal:  J Clin Pathol       Date:  1982-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.